GRAIL (GRAL)
Developer of Galleri and targeted methylation tools for cancer detection.
$108.52
vs last close+0.55 (+0.51%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 89.48% | 38.40M shares | |
|---|---|---|---|
| 394 holders · as of Jun 30, 2026 | |||
| Insiders | 11.21% | 4.81M shares | |
| 9 holders · as of Aug 31, 2026 | |||
| Adds to | 100.69% | ||
42.92M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 100.69%; nothing is left for Other.
13F, as of Jun 30, 2026
394 holders · 38.40M shares · 65 new positions · 181 increased · 103 reduced · 55 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Farallon Capital Management LLC | 4.16M | 9.70% | +907.9K | Aug 14, 2026 |
| Baker Bros. Advisors LP | 4.03M | 9.39% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 3.58M | 8.33% | +608.5K | Aug 7, 2026 |
| State Street Corp | 2.39M | 5.56% | +493.6K | Aug 7, 2026 |
| Primecap Management Co/CA/ | 2.18M | 5.08% | +336.3K | Aug 14, 2026 |
| Sessa Capital Im, L.P. | 2.04M | 4.75% | +318.2K | Aug 14, 2026 |
| Deep Track Capital, LP | 1.83M | 4.28% | +112.1K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.64M | 3.82% | +114.0K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 9.80% | 4.03M | 13G | May 15, 2026 |
| Sessa Capital IM, L.P.incl. John Petry, Capital (Master), L.P. +2 more | 9.66% | 3.00M | 13G | Nov 14, 2024 |
| PRIMECAP Management Company | 7.03% | 2.18M | Nov 12, 2024 | |
| BlackRock, Inc. | 6.50% | 2.33M | 13G | Jul 17, 2025 |
| State Street Corporation | 5.60% | 2.39M | 13G | Aug 7, 2026 |
| CRCM LP | 5.00% | 1.80M | 13G | Oct 6, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 27, 2026 | Aaron Freidinofficer: Chief Financial Officer | Sale | 7,900 | $85.01 | 253,083 |
| Aug 27, 2026 | Joshua J. Ofmandirector, officer: Chief Executive Officer | Sale | 5,000 | $85.02 | 397,271 |
| Jun 4, 2026 | Andrew John Partridgeofficer: Chief Growth Officer | Sale | 1,491 | $61.08 | 163,738 |
| Apr 8, 2026 | Joshua J. Ofmandirector, officer: President | Sale | 61,665 | $49.92 | 371,216 |
| Apr 8, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale | 123,502 | $49.92 | 518,582 |
| Apr 8, 2026 | Aaron Freidinofficer: Chief Financial Officer | Sale | 45,806 | $49.92 | 260,669 |
| Mar 9, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale · 2 lots | 7,461 | $47.89 | 642,084 |
| Mar 5, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale | 980 | $53.01 | 649,545 |
| Mar 9, 2026 | Joshua J. Ofmanofficer: President | Sale · 2 lots | 2,937 | $47.89 | 432,881 |
| Mar 5, 2026 | Joshua J. Ofmanofficer: President | Sale | 690 | $53.01 | 435,818 |
House and Senate disclosures
Not reported.